Career Center
AES Connect
Donate
supervisor_account
check_circle
Get Involved
search
search
Search
menu
Menu
Home
About
About AES
Position Statements
Important Messages from AES
Managing Patients with Epilepsy during COVID-19 | Pharmacotherapy-related Recommendations
Mar 3, 2021, 15:00 PM
COVID-19 | For Patients and Families
Mar 3, 2021, 15:00 PM
COVID-19 | Research Continuity
Mar 3, 2021, 14:59 PM
COVID-19 | Training Continuity
Mar 3, 2021, 14:59 PM
COVID-19 | Treatments
Mar 3, 2021, 14:59 PM
COVID-19 | Telehealth and Remote Care
Mar 3, 2021, 14:45 PM
AES Telehealth Quick Guide
Mar 3, 2021, 14:45 PM
Considerations for Pediatric EMU Admissions Post COVID-19
Mar 3, 2021, 14:24 PM
COVID-19 | Self-management
Mar 3, 2021, 14:13 PM
COVID-19 in patients with seizures and epilepsy: Interpretation of relevant knowledge of presenting signs and symptoms.
Mar 3, 2021, 13:57 PM
COVID-19 | Delivery of Care
Mar 3, 2021, 13:45 PM
Manisha N. Patel, PhD Elected Second Vice President of American Epilepsy Society
Mar 3, 2021, 10:43 AM
CMS Proposed Rule on Medicare Coverage Policy
Mar 2, 2021, 13:16 PM
Robert J. Gumnit, MD
Feb 26, 2021, 14:57 PM
Financial Information
Feb 23, 2021, 19:07 PM
AES eModules
Feb 23, 2021, 09:51 AM
Junior Investigator Research Awards
Feb 22, 2021, 17:48 PM
Research & Training Fellowships for Clinicians
Feb 22, 2021, 17:39 PM
Postdoctoral Research Fellowships
Feb 22, 2021, 15:54 PM
Predoctoral Research Fellowships
Feb 22, 2021, 15:39 PM
1
2
3
4
5
6
7
8
9
10
»
Announcement: New Physician Specialty Code for Epileptologists
We are pleased to announce the implementation of a new physician specialty code-F6, used to indicate the specialty designation for an epileptologist.
July 24, 2024
AES Leadership Role in Development of a National Plan for Epilepsy in Support of IGAP Goals
AES invites steering committee to lead community-wide consensus process to draft a nat'l plan for epilepsy, incorporating input from all stakeholders.
July 18, 2024
FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory from the Ad Hoc ILAE/AES Task Force
Information for clinicians after a safety warning for patients with underlying cardiac disorders/arrhythmias to the PI for lamotrigine.
February 22, 2021
Diversity, Equity, and Inclusion as a Core AES Value: Commitment and Action
The AES Board has created a committee dedicated to accelerating diversity, equity, and inclusion in our Society's work.
February 11, 2021
Underscoring AES Commitments in Challenging Times
January 13, 2021
An Important Message from the American Epilepsy Society on Healthcare Equity and Troubled Times
June 04, 2020